Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
{{output}}
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with limited therapeutic options and poor prognosis. Recent advances in targeted therapies have opened new avenues for intervention in PDAC, focus... ...
